Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
1616O Nab-paclitaxel plus gemcitabine versus modified FOLFIRINOX or S-IROX in metastatic or recurrent pancreatic cancer (JCOG1611, GENERATE): A multicentred, randomized, open-label, three-arm, phase II/III trial
Akihiro Ohba, Masato Ozaka, Gakuto Ogawa, Takuji Okusaka, Satoshi Kobayashi, Tatsuya Yamashita and 14 more
- Rank
- 68 of 3,639
- Percentile
- top 1.9%
- Where
- Annals of Oncology, 2023
- Citations
- 54
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.